Literature DB >> 29729399

High-density mapping and ablation of concealed low-voltage activity within pulmonary vein antra results in improved freedom from atrial fibrillation compared to pulmonary vein isolation alone.

Nathan M Segerson1, Brian Lynch2, Joshua Mozes3, Melinda M Marks3, Daniel K Noonan3, David Gordon3, Pierre Jais4, Marcos Daccarett5.   

Abstract

BACKGROUND: Despite advancements, the goal of durable pulmonary vein isolation (PVI) in all patients undergoing ablation for atrial fibrillation (AF) remains elusive. New high-density mapping (HDM) allows detection of concealed low-voltage signals (CLVSs) that persist after PVI and may represent vulnerabilities in the lesion set.
OBJECTIVE: The purpose of this study was to determine the incidence of CLVSs after PVI and the effect of CLVS ablation on outcomes.
METHODS: We conducted a case control study comparing 150 patients undergoing HDM-guided PVI and subsequent CLVS mapping and ablation (39 redo, 111 de novo) against 452 historical controls undergoing traditional PVI alone. PVI was similarly performed and confirmed in both groups.
RESULTS: Baseline characteristics were similar, except left atrial size was larger in the HDM-guided group. Acute PVI was achieved in nearly all patients in both groups. In the HDM group, 31 of 150 patients exhibited CLVS after luminal PVI, and all were subsequently eliminated. During mean follow-up of 320 days, after controlling for baseline characteristics, the HDM-guided group exhibited a hazard ratio of 0.19 in freedom from AF (P <.001). De novo patients exhibited a hazard ratio of 0.44 relative to redo patients in the HDM-guided group. Both subgroups exhibited significantly lower event rates compared to controls in log-rank analysis (P <.001).
CONCLUSION: CLVSs are commonly identified with HDM after PVI, likely representing vulnerabilities in antral lesion sets. Ablation of these targets seems to significantly improve freedom from AF compared to PVI alone.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Electroanatomic mapping; High density; Low voltage; Pulmonary vein isolation

Mesh:

Year:  2018        PMID: 29729399     DOI: 10.1016/j.hrthm.2018.04.035

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

1.  Comparison between novel and standard high-density 3D electro-anatomical mapping systems for ablation of atrial tachycardia.

Authors:  Philippe Maury; Laure Champ-Rigot; Anne Rollin; Pierre Mondoly; Vanina Bongard; Michel Galinier; Didier Carrié; Emilie Marminia; Stefano Capellino; Lilian Marty; Paul Milliez
Journal:  Heart Vessels       Date:  2018-11-19       Impact factor: 2.037

Review 2.  Mapping of atrial fibrillation: strategies to understand an enigmatic arrhythmia.

Authors:  Isabel Deisenhofer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-09-13

3.  The feasibility and effectiveness of a streamlined single-catheter approach for radiofrequency atrial fibrillation ablation.

Authors:  Shui Hao Chin; Jim O'Brien; Gianluca Epicoco; Prithvi Peddinti; Akanksha Gupta; Simon Modi; Johan Waktare; Richard Snowdon; Dhiraj Gupta
Journal:  J Arrhythm       Date:  2020-06-26

4.  Advanced mapping strategies for ablation therapy in adults with congenital heart disease.

Authors:  Fares-Alexander Alken; Niklas Klatt; Paula Muenkler; Katharina Scherschel; Christiane Jungen; Ruken Oezge Akbulak; Ann-Kathrin Kahle; Melanie Gunawardene; Mario Jularic; Leon Dinshaw; Jens Hartmann; Christian Eickholt; Stephan Willems; Fridrike Stute; Goetz Mueller; Stefan Blankenberg; Carsten Rickers; Christoph Sinning; Elvin Zengin-Sahm; Christian Meyer
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

5.  High Power Ultra Short Duration Ablation with HD Grid Improves Freedom from Atrial Fibrillation and Redo Procedures Compared to Circular Mapping Catheter.

Authors:  Brian Crandall; Sriharsha Kanuri; Michael Cutler; Jeffrey Osborn; Jared Miller; Charles Mallender; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2020-08-31

6.  Comparison of ablation outcomes of the second ablation procedure for recurrent atrial fibrillation using an ultra-high-resolution mapping system and conventional mappings system.

Authors:  Masaharu Masuda; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Yasuhiro Matsuda; Shota Okuno; Aki Tsuji; Toshiaki Mano
Journal:  Clin Cardiol       Date:  2019-08-12       Impact factor: 2.882

7.  Improved procedural workflow for catheter ablation of paroxysmal AF with high-density mapping system and advanced technology: Rationale and study design of a multicenter international study.

Authors:  Francesco Solimene; Giuseppe Stabile; Pablo Ramos; Luca Segreti; Filippo Maria Cauti; Valerio De Sanctis; Ruggero Maggio; Javier Ramos-Maqueda; Lluis Mont; Vincenzo Schillaci; Maurizio Malacrida; Ignacio Garcia-Bolao
Journal:  Clin Cardiol       Date:  2022-04-21       Impact factor: 3.287

8.  A case report of an important role of epicardial connections in producing spontaneous pulmonary vein activity and initiating and maintaining atrial fibrillation.

Authors:  Keishiro Yagyu; Masao Takemoto; Masaki Fujiwara; Yoshibumi Antoku; Tokushi Koga; Takuya Tsuchihashi
Journal:  HeartRhythm Case Rep       Date:  2022-07-03

Review 9.  Novel approaches to mechanism-based atrial fibrillation ablation.

Authors:  Jorge G Quintanilla; Shlomo Shpun; José Jalife; David Filgueiras-Rama
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

10.  Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial.

Authors:  Shouvik Haldar; Habib Rehman Khan; Vennela Boyalla; Ines Kralj-Hans; Simon Jones; Joanne Lord; Oluchukwu Onyimadu; Anitha Satishkumar; Toufan Bahrami; Anthony De Souza; Jonathan R Clague; Darrel P Francis; Wajid Hussain; Julian W Jarman; David Gareth Jones; Zhong Chen; Neeraj Mediratta; Jonathan Hyde; Michael Lewis; Raad Mohiaddin; Tushar V Salukhe; Caroline Murphy; Joanna Kelly; Rajdeep S Khattar; William D Toff; Vias Markides; James McCready; Dhiraj Gupta; Tom Wong
Journal:  Eur Heart J       Date:  2020-12-14       Impact factor: 29.983

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.